UI marrow drive aims to help leukemia patients, others The Gazette Tue, 31 Mar 2009 14:00 PM PDT IOWA CITY and#8212; Six-year-old Rian Bevan loves her kindergarten class at Washington Elementary in Mount Vernon, watching the Discovery Channel and doing crafts.But since her leukemia diagnosis at age 4, Rian, the daughter of Angela and Jason Johnson of Mount Vernon, has spent much of the last two years hospitalized.Her cancer is not only in her blood, but her brain and spinal column, as well, ... | EP to test air around 62 schools in 22 states, including Burkburnett KSWO Lawton-Wichita Falls Tue, 31 Mar 2009 13:59 PM PDT The Environmental Protection Agency will put air pollution monitors in dozens of school yards around the country - including some in Texas. The EPA, Tuesday, announced a list of 62 schools in 22 states where the outdoor air will be tested for toxic contaminants. The focus is toxic chemicals that are known to cause cancer, respiratory and neurological problems - especially in children. | Patient: Delayed claim may affect her care Tulsa World Tue, 31 Mar 2009 13:57 PM PDT A shop that carries supplies for women with can- cer also cites woes. OKLAHOMA CITY â" Louise Wren could rely on her husband's state insurance plan to pay half the cost of a wig to cover the loss of hair caused by cancer treatments. Until Monday. | Confusion in prostate cancer screening is academic Savannah Morning News Tue, 31 Mar 2009 13:56 PM PDT If I were a medical school dean, I would require all physician-scientists on the faculty to watch every John Wayne and Clint Eastwood movie before they attempt to complete a research program. | Brain cancer drug may get accelerated approval MSNBC Tue, 31 Mar 2009 13:52 PM PDT Preliminary studies of a blockbuster drug from Roche's Genentech unit are strong enough to speed up its approval for brain cancer, federal cancer experts said Tuesday. | Mother Charged In Denying Cancer Meds To Son WBUR Boston Tue, 31 Mar 2009 13:49 PM PDT The mother of a 9-year-old boy who died of cancer is charged with reckless child endangerment for allegedly withholding her son's medication. | Genzyme to pay Bayer up to $2.8B for MS, cancer drugs Mass High Tech Tue, 31 Mar 2009 13:43 PM PDT Genzyme Corp. has entered a deal with Bayer HealthCare in which the Cambridge biotech giant will pay up to $2.8 billion to acquire three Bayer drugs -- Campath, to treat multiple sclerosis, and Fludara and Leukine as cancer treatments. The deal requires no upfront payments. | | |
|
No comments:
Post a Comment